article thumbnail

DEA Regs Bulk Up with 2014 Anabolic Steroid Control Law Additions

FDA Law Blog: Biosimilars

Houck — Anabolic steroids that include testosterone, methyltestosterone, nandrolone decanoate and oxandrolone are schedule III controlled substances with currently accepted medical uses in the U.S. DASCA amended the CSA definition of “anabolic steroid” by adding 22 new substances to the prior list. By Larry K.

article thumbnail

Senators to DEA: Consider Treaty Obligations In Marijuana Rescheduling

FDA Law Blog: Biosimilars

Milgram’s predecessors, and Directors of National Drug Policy urging not to reschedule; the January 2004 letter Democratic state attorneys general pushing for rescheduling to schedule III; and the January 2024 letter from Democratic senators requesting descheduling altogether.